These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26567906)

  • 1. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Serratia marcescens in China.
    Yang HF; Cheng J; Hu LF; Ye Y; Li JB
    J Antibiot (Tokyo); 2012 Oct; 65(10):531-3. PubMed ID: 22854338
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression analysis of the SdeAB multidrug efflux pump in antibiotic-resistant clinical isolates of Serratia marcescens.
    Dalvi SD; Worobec EA
    Indian J Med Microbiol; 2012; 30(3):302-7. PubMed ID: 22885196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the antibiotic resistance rates of
    Simsek M
    Niger J Clin Pract; 2019 Jan; 22(1):125-130. PubMed ID: 30666031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of virulence factors in Serratia strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Carta A; Zanetti S
    Acta Ophthalmol; 2011 Jun; 89(4):382-7. PubMed ID: 19845561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SME-2-producing Serratia marcescens isolate from Switzerland.
    Poirel L; Wenger A; Bille J; Bernabeu S; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2282-3. PubMed ID: 17420208
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicenter surveillance of antimicrobial resistance in Serratia marcescens in Taiwan.
    Liou BH; Duh RW; Lin YT; Lauderdale TL; Fung CP;
    J Microbiol Immunol Infect; 2014 Oct; 47(5):387-93. PubMed ID: 23751769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of The Pathogenic Potential of Insecticidal
    Konecka E; Mokracka J; Krzymińska S; Kaznowski A
    Pol J Microbiol; 2019; 68(2):185-191. PubMed ID: 31257791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods to determine antipathogenic potential of phenolic and flavonoid compounds against urinary pathogen Serratia marcescens.
    Annapoorani A; Parameswari R; Pandian SK; Ravi AV
    J Microbiol Methods; 2012 Oct; 91(1):208-11. PubMed ID: 22759832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACT-10, a novel plasmid-encoded class C β-lactamase in a Serratia marcescens isolate from China.
    Ma XJ; Yang HF; Liu YY; Mei Q; Ye Y; Li HR; Cheng J; Li JB
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):343-4. PubMed ID: 25312010
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoroquinolone resistance of Serratia marcescens: sucrose, salicylate, temperature, and pH induction of phenotypic resistance.
    Begic S; Worobec EA
    Can J Microbiol; 2007 Nov; 53(11):1239-45. PubMed ID: 18026218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of Serratia marcescens Coproducing ArmA and CTX-M-15 Mediated High Levels of Resistance to Aminoglycoside and Extended-Spectrum Beta-Lactamases, Algeria.
    Batah R; Loucif L; Olaitan AO; Boutefnouchet N; Allag H; Rolain JM
    Microb Drug Resist; 2015 Aug; 21(4):470-6. PubMed ID: 25884511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serratia infections in patients with neutropenia.
    Hartmann F; Gheorghiu T; Leupold H; Baer F; Diehl V
    Klin Wochenschr; 1991 Aug; 69(11):491-4. PubMed ID: 1921232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of contact lens multipurpose solutions against serratia marcescens.
    Hume EB; Zhu H; Cole N; Huynh C; Lam S; Willcox MD
    Optom Vis Sci; 2007 Apr; 84(4):316-20. PubMed ID: 17435515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial strain of Serratia marcescens producing a new type of extended spectrum beta-lactamase transfers multidrug resistance.
    Babalova M; Blahova J; Kralikova K; Krcmery V; Jezek P; Rovny I
    J Chemother; 2006 Jun; 18(3):334-5. PubMed ID: 17129849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.